INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "BAFFR X CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE"

GENEVA, Oct. 28 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/024557) for "BAFFR X CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE" on Apr 14, 2025. With publication no. WO/2025/221674, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BURNS, Colleen Ann (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), CHAKROUN, Nesrine (c/o Merus N.V.Uppsalalaan 17, 3e en 4e Verdieping3584 Utrecht), DE KRUIF, Cornelis Adriaan (c/o Merus N.V.Uppsalal...